1. Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Authors' reply. Issue 1 (2nd December 2016) Authors: Bantel, H.; Wandrer, F.; Bock, B.; Kirstein, M. M.; Schulze‐Osthoff, K. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 1(2017) Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Authors' reply. Issue 1 (January 2017) Authors: Bantel, H.; Wandrer, F.; Bock, B.; Kirstein, M. M.; Schulze‐Osthoff, K. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 1(2017) Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection. Issue 3 (4th June 2018) Authors: Wandrer, F.; Han, B.; Liebig, S.; Schlue, J.; Manns, M. P.; Schulze‐Osthoff, K.; Bantel, H. Journal: Alimentary pharmacology & therapeutics Issue: Volume 48:Issue 3(2018) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Serum cell death biomarker mirrors liver cancer regression after transarterial chemoembolisation. Issue 7 (3rd August 2016) Authors: Bock, B.; Hasdemir, D.; Wandrer, F.; Rodt, T.; Manns, M. P.; Schulze‐Osthoff, K.; Bantel, H. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 7(2016) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗